Thu, Sep 18, 2014, 12:48 PM EDT - U.S. Markets close in 3 hrs 12 mins


% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • blackoutbuzz blackoutbuzz Nov 22, 2011 9:10 PM Flag

    SHPGY expands US operations

    Looks like business is going well in rare diseases.

    LEXINGTON, Massachusetts, November 22, 2011 /PRNewswire/ --
    Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted regulatory filings with both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for the production of VPRIV® (velaglucerase alfa) in its state-of-the-art manufacturing facility at 400 Shire Way in Lexington, Massachusetts. Subject to regulatory approval, which is anticipated in early 2012, Shire expects the new plant to significantly increase manufacturing capacity and allow for increased global supply of VPRIV. These approvals will also make available further capacity for the manufacture of Replagal® (agalsidase alfa) at Shire's Alewife facility, where both VPRIV and Replagal are currently manufactured.

260.61+0.12(+0.05%)12:47 PMEDT